#contraceptives market trends

[mitalipingale]

The Contraceptives Market in 2023 is US$ 31.97 billion, and is expected to reach US$ 53.78 billion by 2031 at a CAGR of 6.70%.

[tbrcresearchreport]

The Business Research Company offers contraceptives market research report 2023 with industry size, share, segments and market growth

[roseaa11]

Data Bridge Market Research analyses a growth rate in the hormonal contraceptive market in the forecast period 2023-2030. The expected CAGR of the hormonal contraceptive market tends to be around 4.60% in the mentioned forecast period. The market was valued at USD 16.6 billion in 2022 and would grow to USD 23.79 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

[marketspace360]

Hormonal Contraceptives Market | Manufacturers, Regions, Type and Application, Forecast by 2029

[market-insider]

U.S. Contraceptive Market Showing Rapid Growth In Subdermal Implants Segments

The U.S. contraceptive market size is expected to reach USD 12.0 billion by 2030 registering a CAGR of 4.70%, according to a new report by Grand View Research, Inc. Improving access and awareness regarding Long-Acting Reversible Contraceptives (LARCs) and the effectiveness and convenience of using these products are expected to drive the growth of the industry. The Guttmacher Institute reported that 60% of women belonging to the reproductive age use contraception in the U.S. Use of hormonal contraceptives other than the birth control pill has significantly increased in married women.

Gain deeper insights on the market and receive your free copy with TOC now @: U.S. Contraceptive Market Report

The increasing availability of contraceptives in the U.S. has improved several aspects of society such as education, career opportunities, and poverty for women. Access to modern methods of contraception has significantly improved career opportunities and allowed women to earn wages at par with men. Moreover, it has also reduced the number of women living in poverty due to unintended pregnancies and the high costs associated with raising a child. The legalization of family planning in the majority of the states has reduced the economic burden for the next generation as there has been a substantial reduction in the number of citizens living in poverty as adults.

The onset of the COVID-19 pandemic has showcased a negative impact on the market partially offsetting the initiatives by manufacturers. Short-term contraceptives such as birth control pills and condoms require re-prescription filling and frequent purchase, which may increase the risk of exposure to the virus. Thus, usage of these products has been limited during the pandemic. Moreover, the availability and distribution of contraceptives at public healthcare centers have been impacted in the U.S. Unemployment and loss of insurance that covers expenses of contraceptives in the U.S. are also anticipated to limit usage during the COVID-19 pandemic.

[insightslicelive]

Hormonal Contraceptives Market Sales Statistics, Key Players, Growth Projection Outlook to 2032 | Ansell LTD., Bayer AG, BioSante Pharmaceuticals Inc., Boehringer Ingelheim GmbH

Hormonal Contraceptives Market Sales Statistics, Key Players, Growth Projection Outlook to 2032 | Ansell LTD., Bayer AG, BioSante Pharmaceuticals Inc., Boehringer Ingelheim GmbH

insightSLICE has compiled key insights and presented a research report on market titled “Global Hormonal Contraceptives Market 2023”: The report begins with an overview of the industrial environment, analysis of market size, by-products, regions, application, industry competition within active companies. The research analyzes market share, demand, trends and forecast in the coming years. The…

[v-r-lifescience]

https://www.einpresswire.com/article/681858386/contraceptive-market-size-growing-at-6-9-cagr-set-to-reach-usd-50-596-billion-by-2030-exclusive-report

[beardedmrbean]

North Korean authorities have been punishing doctors who carry out abortions and the providers of contraceptives amid a drive by the country to boost its birth rate, according to a recent report.

Radio Free Asia cited a medical field source in the northern province of Ryanggang, which borders China, in its article. The source, who requested anonymity for their own safety, said the head of the obstetrics and gynecology department of Paegam County Hospital was put on trial for having conducted at-home abortions.

The doctor, who conducted one abortion at home that resulted in the death of the woman, was sentenced to five years in prison, according to Radio Free Asia. His trial was held in a conference room of a medical university hospital.

North Korea's fertility rate, or the number of babies expected per woman's lifetime, dropped to 1.8 births per woman last year, per estimates by the United Nations Population Fund. A fertility rate of 2.1 is considered the minimum rate necessary for a population to sustain itself over time.

An OB-GYN working at a hospital in Unhung County, another administrative unit in Ryanggang, was handed a three-year sentence. She had previously been sanctioned for illegally terminating a pregnancy in 2021.

The pair carried out the clandestine abortions at home, as many as three in a day, according to the source. The procedures reportedly cost 30,000 North Korean won ($33), equivalent to an average monthly salary and enough to buy 10 pounds of rice.

"Typically, OB-GYN doctors go to a pregnant woman's home to perform abortions in order to leave no trace, but these two doctors had set up medical equipment in their own homes," the source said.

They added that the department head in Paegam County had reached retirement age this year. The Unhung County doctor has two daughters who are middle school students.

RFA cited sources who said the government had raised doctors' salaries by a factor of 40, now ranging between $5-$11 won per month, to disincentivize earning extra money outside of their regular jobs.

Vendors of contraceptives are also reportedly being targeted, another source told the outlet.

She said she knew of two such merchants in the city of Hyesan who had their stalls seized by authorities in July. Late last month, three others were issued with heavy fines and had their booths confiscated.

These vendors were also banned from conducting business in the market ever again.

The North Korean embassy in China didn't immediately respond to a written request for comment.

North Korea banned abortions during the "Arduous March," a period of extreme economic hardship and famine that gripped the country between 1994 and 1998, with deaths ranging from hundreds of thousands to upwards of 2 million.

North Korea's demographic crunch is also a concern for its neighbors, whose policies to encourage births are so far failing to bear fruit. The fertility rate stands at 1.4 in Russia, 1.2 in Japan, 1.0 in China, 0.85 in Taiwan and 0.72 in South Korea.

However, North Korea is even more susceptible to the negative impact of the trend because of international embargoes on advanced machinery, imposed over Pyongyang's missile and nuclear weapons programs. The country therefore continues to rely more on physical labor and outdated production techniques than other countries in the region.

Late last year, in remarks during the country's fifth National Congress of Mothers, North Korean leader Kim Jong Un named the declining birthrate as one of the country's major social challenges and appealed to North Korean women to do their part to reverse the trend.

[jainhospitalkhanna]

Gynaecology (Menarche To Menopause, PCOS + PCOD, Taboos & Cervical Cancer)

In this episode of our podcast, we sit down with Dr. Jyotika, an esteemed gynaecologist, who explores a wide range of topics crucial to women's health. Starting from the Menarche to Menopause, Dr. Jyotika addresses common concerns such as the causes of irregular periods, why puberty is hitting sooner these days, what kind of changes a girl/ woman’s body goes through, foods that can help regulate the menstrual cycle, and the differences between PCOD and PCOS.

We delve into the subjects that are taboo in society such as vaginal odours and different colour discharges, why some women experience pain during sex, and the causes of breast soreness during periods. Additionally, we discuss whether it is normal to feel pressure in the pelvis and vagina, how to control cravings during PMS, and the various birth control options available. Dr. Jyotika emphasises the importance of Kegel exercises for pelvic muscles, the consumption and side effects of contraceptives, and critical discussion on cervical cancer marketing campaign executed by Poonam Pandey.

We also tackle controversial topics, including breaking the myth about how safe are C-sections & a woman is never “Too Posh To Push”, the health implications of the pill, whether endometriosis is overhyped or underdiagnosed, and the reality of pelvic floor problems and their solutions.

Dr. Jyotika provides her expert view on how hysterectomy is certain & safe in some cases, the trend of vaginal tightening whether it’s for empowerment or exploitation, the different sizes of breasts, and the impact of the HPV vaccine. Finally, we uncover how we can prevent Cervical Cancer at the starting stage.

Tune in for an enlightening conversation filled with expert insights and candid discussions on women's health issues.

GET IN TOUCH WITH US

📞 +91-98557-44429

WhatsApp No. 77106-44429

Emergency No:- 99886-34400

Address: Near Dussehra Ground, Distt, opposite Electricity Board, Khanna, Punjab 141401

[credenceresearchdotblog]

The demand for Contraceptives market was valued at USD 29154.2 Million in 2023 and is expected to reach USD 52703.8 Million in 2032, growing at a CAGR of 6.80% between 2024 and 2032.The contraceptives market has seen remarkable growth over the past few years, driven by increased awareness about family planning, rising incidence of sexually transmitted infections (STIs), and government initiatives promoting reproductive health. The market encompasses a wide range of products, including hormonal pills, intrauterine devices (IUDs), condoms, injectables, implants, and emergency contraceptives. As of 2024, the global contraceptives market is poised to continue its upward trajectory, fueled by technological advancements, changing social norms, and the ongoing need for effective birth control methods.

Browse the full report at https://www.credenceresearch.com/report/contraceptives-market

Market Overview

The global contraceptives market was valued at approximately $32 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of around 6-7% through 2030. This growth is attributed to several factors, including increasing awareness about contraception methods, the rising prevalence of unplanned pregnancies, and the need for effective family planning solutions. The market is segmented into two major categories: contraceptive drugs (oral pills, injectables, patches) and contraceptive devices (condoms, IUDs, vaginal rings).

Key Drivers of Market Growth

1. Rising Awareness and Education: One of the most significant drivers of the contraceptives market is the increased awareness about family planning and sexual health. Governments, non-governmental organizations (NGOs), and healthcare providers are actively involved in educating the public about the benefits of using contraceptives, which has led to higher adoption rates.

2. Government Initiatives and Support: Various governments across the world have launched initiatives to promote the use of contraceptives as part of their efforts to control population growth and reduce maternal mortality rates. Programs like the Family Planning 2020 initiative and various national schemes provide free or subsidized contraceptives to women in low- and middle-income countries, significantly boosting market growth.

3. Technological Advancements: The development of new and improved contraceptive products, such as long-acting reversible contraceptives (LARCs) like hormonal IUDs and implants, has revolutionized the market. These products offer greater convenience, efficacy, and fewer side effects, making them popular choices among women.

4. Changing Social Norms: As societal attitudes towards sex, family planning, and reproductive rights evolve, there is a growing acceptance of contraceptives. The increasing participation of women in the workforce, the trend towards smaller families, and the empowerment of women to make their own reproductive choices are all contributing to market growth.

Challenges Facing the Market

Despite the positive outlook, the contraceptives market faces several challenges:

1. Cultural and Religious Barriers: In many regions, particularly in conservative societies, the use of contraceptives is still frowned upon due to cultural and religious beliefs. This creates barriers to market penetration and limits access to contraceptive products.

2. Side Effects and Health Concerns: Some contraceptive methods, especially hormonal pills and injectables, can cause side effects such as weight gain, mood swings, and nausea, which deter some women from using them. There is a growing demand for safer, side-effect-free alternatives.

3. Limited Access in Rural Areas: In low-income and rural areas, access to contraceptives remains a significant issue. Poor infrastructure, lack of healthcare facilities, and limited supply chains hinder the availability of contraceptive products, particularly in developing countries.

Regional Insights

The contraceptives market shows varying growth patterns across different regions. North America and Europe are mature markets with high contraceptive usage rates due to well-established healthcare systems and widespread awareness. The Asia-Pacific region, on the other hand, is witnessing rapid growth due to increasing government initiatives and rising awareness, particularly in countries like India and China. Africa remains a high-potential market with significant unmet needs, as efforts continue to increase access to contraception.

Future Outlook

The future of the contraceptives market looks promising, with continued growth expected due to increasing demand for effective birth control methods. Innovation will play a crucial role, with companies focusing on developing more user-friendly and non-invasive products. Additionally, digital platforms that provide information and access to contraceptives are set to further boost market growth.

As societal norms continue to evolve and awareness about reproductive health grows, the contraceptives market is expected to expand, providing individuals with more options and greater control over their reproductive choices. The focus will remain on improving accessibility, reducing side effects, and ensuring that contraceptives are available to all, regardless of geographical or socio-economic barriers.

Key Players

Abbvie Inc

Pfizer Inc

Ansell Ltd

Mayer Laboratories Inc

The Cooper Companies Inc

Bayer AG

Teva Pharmaceutical Industries Limited

Merck & Co Inc

Veru Inc

Church & Dwight Co Inc

Segmentation

By Product Type:

Contraceptive Drugs

Oral Contraceptives (Combined Oral Contraceptives, Progestin-Only Pills)

Contraceptive Injectable

Contraceptive Patches

Contraceptive Implants

Contraceptive Devices

Male Condoms

Female Condoms

Diaphragms

Cervical Caps

Intrauterine Devices (IUDs)

Contraceptive Sponges

By End-User:

Hospital Pharmacies

Retail Pharmacies

Online Channels

By End-User:

Hospitals and Clinics

Home Care Settings

By Age Group:

Adolescents

Adults

By Mode of Prescription:

Prescription-based Contraceptives

Over-the-Counter (OTC) Contraceptives

By Hormonal vs. Non-Hormonal:

Hormonal Contraceptives

Combination Hormonal Methods

Progestin-Only Hormonal Methods

Non-Hormonal Contraceptives

Barrier Methods

Intrauterine Devices (Copper IUDs)

By Region

North America

US

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/contraceptives-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[tamanna31]

Condom 2024 Industry – Challenges, Drivers, Outlook, Segmentation - Analysis to 2030

Condom Industry Overview

The global condom market size was estimated at USD 11.59 billion in 2023 and is expected to grow at a CAGR of 8.72% from 2024 to 2030. The increase in awareness regarding the use of condoms, measures to reduce the spread of HIV & other Sexually Transmitted Infections (STIs), and the availability of different types of products to suit consumer needs are likely to drive market growth during the forecast period.

According to the World Health Organization (WHO) in 2023, approximately 374 million new cases of syphilis, gonorrhea, chlamydia, and trichomoniasis were reported annually. In the same year, WHO reported that 39.0 million people were living with HIV globally, with two-thirds of them residing in the African countries. This can lead to serious complications beyond the immediate effect of the infection itself. If left untreated, STDs can lead to complications such as impotence and infertility. According to a study published on Factors associated with adverse pregnancy outcomes of maternal syphilis in Henan, China, 2016-2022, in 2016, around 1 million pregnant women were detected with active syphilis, which resulted in 200,000 stillbirths and 350,000 adverse birth outcomes. This is expected to boost demand for the use of condoms during the forecast period.

Gather more insights about the market drivers, restrains and growth of the Condom Market

The male condom segment dominated the market with a revenue share of 98.74% in 2023. The growth can be attributed to factors such as manufacturers' focus on the production of male condoms, open-mindedness regarding their use as compared to female condoms, and diverse portfolios. Underdeveloped countries in Africa have a high unmet demand for male condoms due to the increasing prevalence of HIV/AIDS. These are mostly the preferred option among couples, resulting in higher demand.

Moreover, male condoms have a variety of options in terms of materials, thickness, designs, and colors, which promotes their use. They are commonly used methods of contraception. According to the U.S. Census data and Simmons National Consumer Survey data, around 33.44 million Americans used condoms in 2020. This is anticipated to drive the segment growth during the forecast period.

The female condom segment is estimated to witness the fastest CAGR during the forecast period. These are being increasingly accepted for reducing the risk of STIs and unplanned pregnancies. Despite female condoms being a lifesaving product and easy availability, their distribution & use are quite low as most of the family planning and HIV prevention programs have not embraced female condoms. However, female condoms are gaining immense popularity of late, especially among single women.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global intrauterine devices market size was estimated at USD 6.25 billion in 2023 and is projected to grow at a CAGR of 3.66% from 2024 to 2030.

• The global dual chamber prefilled syringes market size was valued at USD 167.3 million in 2023 and is projected to grow at a CAGR of 5.8% from 2024 to 2030.

Key Condom Company Insights

The market is highly competitive, with the presence of multiple major players. The market is witnessing the presence of numerous country-level players, alongside the introduction of smaller competitors poised to gain a substantial market share. This trend is reflective of the competitive landscape in the industry. Some emerging players in the market are, Jems and Slipp in Canada, Bleu in India, Get Down and Jonny in Australia, and Hanx in the UK.

Key Condom Companies:

The following are the leading companies in the condom market. These companies collectively hold the largest market share and dictate industry trends.

FUJILATEX CO.,LTD

Reckitt Benckiser Group PLC

Church & Dwight Co., Inc.

Karex Berhad

LELO iAB

Lifestyles

Veru Inc.

Okamoto Industries, Inc

MAYER LABORATORIES, INC.

Cupid Limited

RITEX GMBH

Pasante Healthcare Ltd.

CPR GmbH

Mankind Pharma

Sagami Rubber Industries Co., Ltd.

rrtMedcon

Recent Developments

In April 2023, Veru Inc. has entered into a Purchasing Agreement with Afaxys Group Services, LLC (AGS) to offer Veru’s FC2 Female Condom (internal condom) through the AGS Group Purchasing Organization (GPO). This agreement will benefit up to 31 million women and men who depend on community & public health centers for essential healthcare.

In May 2021, SKYN, the leading sexual wellness brand and maker of the nonlatex condom, has launched SKYN Excitation, a new condom with a unique wave design featuring raised dots on the most sensitive areas. This new product is set to enhance the sexual experience for those who use it.

Order a free sample PDF of the Condom Market Intelligence Study, published by Grand View Research.